Back to Search
Start Over
Acute spinal cord injury (SCI) transforms how GABA affects nociceptive sensitization.
- Source :
-
Experimental neurology [Exp Neurol] 2016 Nov; Vol. 285 (Pt A), pp. 82-95. Date of Electronic Publication: 2016 Sep 15. - Publication Year :
- 2016
-
Abstract
- Noxious input can sensitize pain (nociceptive) circuits within the spinal cord, inducing a lasting increase in spinal cord neural excitability (central sensitization) that is thought to contribute to chronic pain. The development of spinally-mediated central sensitization is regulated by descending fibers and GABAergic interneurons. The current study provides evidence that spinal cord injury (SCI) transforms how GABA affects nociceptive transmission within the spinal cord, recapitulating an earlier developmental state wherein GABA has an excitatory effect. In spinally transected rats, noxious electrical stimulation and inflammation induce enhanced mechanical reactivity (EMR), a behavioral index of nociceptive sensitization. Pretreatment with the GABA <subscript>A</subscript> receptor antagonist bicuculline blocked these effects. Peripheral application of an irritant (capsaicin) also induced EMR. Both the induction and maintenance of this effect were blocked by bicuculline. Cellular indices of central sensitization [c-fos expression and ERK phosphorylation (pERK)] were also attenuated. In intact (sham operated) rats, bicuculline had the opposite effect. Pretreatment with a GABA agonist (muscimol) attenuated nociceptive sensitization in intact, but not spinally injured, rats. The effect of SCI on GABA function was linked to a reduction in the Cl <superscript>-</superscript> transporter, KCC2, leading to a reduction in intracellular Cl <superscript>-</superscript> that would attenuate GABA-mediated inhibition. Pharmacologically blocking the KCC2 channel (with i.t. DIOA) in intact rats mimicked the effect of SCI. Conversely, a pharmacological treatment (bumetanide) that should increase intracellular Cl <superscript>-</superscript> levels blocked the effect of SCI. The results suggest that GABAergic neurons drive, rather than inhibit, the development of nociceptive sensitization after spinal injury.<br /> (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Subjects :
- Acetates pharmacology
Analysis of Variance
Animals
Bicuculline pharmacology
Bumetanide pharmacology
Capsaicin adverse effects
Disease Models, Animal
GABA Agents pharmacology
Gene Expression Regulation drug effects
Indenes pharmacology
Lipopolysaccharides pharmacology
MAP Kinase Signaling System drug effects
Male
Muscimol pharmacology
Nociception drug effects
Pain Measurement
Physical Stimulation adverse effects
Proto-Oncogene Proteins c-fos metabolism
RNA, Messenger metabolism
Rats
Rats, Sprague-Dawley
Sodium Potassium Chloride Symporter Inhibitors pharmacology
Symporters metabolism
Time Factors
K Cl- Cotransporters
Hyperalgesia drug therapy
Hyperalgesia physiopathology
Nociception physiology
Spinal Cord Injuries physiopathology
gamma-Aminobutyric Acid metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1090-2430
- Volume :
- 285
- Issue :
- Pt A
- Database :
- MEDLINE
- Journal :
- Experimental neurology
- Publication Type :
- Academic Journal
- Accession number :
- 27639636
- Full Text :
- https://doi.org/10.1016/j.expneurol.2016.09.005